Advertisement

Psychopharmacology

, Volume 193, Issue 2, pp 295–304 | Cite as

Anti-aggressive effects of agonists at 5-HT1B receptors in the dorsal raphe nucleus of mice

  • Makoto Bannai
  • Eric W. Fish
  • Sara Faccidomo
  • Klaus A. MiczekEmail author
Original Investigation

Abstract

Rationale

In rodents, serotonin 1B (5-HT1B) agonists specifically reduce aggressive behaviors, including several forms of escalated aggression. One form of escalated aggression is seen in mice that seek the opportunity to attack another mouse by accelerating their responding during a fixed interval (FI) schedule. Responses preceding the opportunity to attack may reflect aggressive motivation.

Objective

This study investigated the effects of two 5-HT1B receptor agonists on the motivation to fight and the performance of heightened aggression.

Materials and methods

Male mice were housed as “residents” and performed nose-poke responses on an FI 10-min schedule with the opportunity to briefly attack an “intruder” serving as the reinforcer. In the first experiment, the 5-HT1B receptor agonist, CP-94,253 (0–10 mg/kg, IP), was given 30 min before the FI 10 schedule. To confirm that CP-94,253 achieved its effects via 5-HT1B receptors, the 5HT1B/1D receptor antagonist, GR 127935 (10 mg/kg, IP) was administrated before the agonist injection. In the second experiment, the 5-HT1B agonist CP-93,129 (0–1.0 μg) was microinjected into the dorsal raphe 10 min before the FI 10 schedule.

Results

The agonists had similar effects on all behaviors. CP-94,253 and CP-93,129 significantly reduced the escalated aggression towards the intruder at doses lower than those required to affect operant responding. The highest doses of CP-94,253 (10 mg/kg) and CP-93,129 (1.0 μg) decreased the rate and accelerating pattern of responding during the FI 10 schedule; lower doses were less effective. GR 127935 antagonized CP-94,253’s effects on all other behaviors, except response rate.

Conclusions

These data extend the anti-aggressive effects of 5-HT1B agonists to a type of escalated aggression that is rewarding and further suggest that these effects are associated with actions at 5-HT1B receptors in the dorsal raphe.

Keywords

5-HT1B receptor Aggression Microinjection Reinforcement Operant conditioning Intruder 

Notes

Acknowledgments

This research was supported by a grant from the NIAAA (KAM) and by the Research Institute for Health Fundamentals, Ajinomoto Co., Inc.

References

  1. Adell A, Celada P, Artigas F (2001) The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain. J Neurochem 79:172–182PubMedCrossRefGoogle Scholar
  2. Azrin NH, Hutchinson RR, McLaughlin R (1965) The opportunity for aggression as an operant reinforcer during aversive stimulation. J Exp Anal Behav 8:171–180PubMedCrossRefGoogle Scholar
  3. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083–1152PubMedCrossRefGoogle Scholar
  4. Barratt ES (1993) The use of anticonvulsants in aggression and violence. Psychopharmacol Bull 29:75–81PubMedGoogle Scholar
  5. Bell R, Donaldson C, Gracey D (1995) Differential effects of CGS 12066B and CP-94,253 on murine social and agonistic behaviour. Pharmacol Biochem Behav 52:7–16PubMedCrossRefGoogle Scholar
  6. Bouwknecht JA, Hijzen TH, van der Gugten J, Maes RA, Hen R, Olivier B (2001) Absence of 5-HT(1B) receptors is associated with impaired impulse control in male 5-HT(1B) knockout mice. Biol Psychiatry 49:557–568PubMedCrossRefGoogle Scholar
  7. Buckley PF (1999) The role of typical and atypical antipsychotic medications in the management of agitation and aggression. J Clin Psychiatry 60(Suppl 10):52–60PubMedGoogle Scholar
  8. Celada P, Puig MV, Casanovas JM, Guillzo G, Artigas F (2001) Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A GABAA and glutamate receptors. J Neurosci 21:9917–9929PubMedGoogle Scholar
  9. Chauloff F, Courvoisier H, Moisan MP, Mormede P (1999) GR 127935 reduces basal locomotor activity and prevents RU 24969-, but not d-amphetamine-induced hyperlocomotion in the Wistar–Kyoto hyperactive (WKHA) rat. Psychopharmacology 141:326–331CrossRefGoogle Scholar
  10. Cherek DR, Thompson T, Heistad GT (1973) Responding maintained by the opportunity to attack during an interval food reinforcement schedule. J Exp Anal Behav 19:113–123PubMedCrossRefGoogle Scholar
  11. Clark MS, Neumaier JF (2001) The 5-HT1B receptor: behavioral implications. Psychopharmacol Bull 35:170–185PubMedGoogle Scholar
  12. Connor JL (1974) Waning and recovery of conspecific aggression in the house mouse (Mus musculus L). J Comp Physiol Psychol 87:215–227PubMedCrossRefGoogle Scholar
  13. Corvaja N, Doucet G, Bolam JP (1993) Ultrastructure and synaptic targets of the raphé–nigral projection in the rat. Neuroscience 55:417–427PubMedCrossRefGoogle Scholar
  14. Crowley TJ, Stynes AJ, Hydinger M, Kaufman IC (1974) Ethanol, methamphetamine, pentobarbital, morphine, and monkey social behavior. Arch Gen Psychiatry 31:829–838PubMedGoogle Scholar
  15. de Almeida RMM, Lucion AB (1997) 8-OH-DPAT in the median raphe, dorsal periaqueductal gray and corticomedial amygdala nucleus decreases, but the medial septal area it can increase maternal aggressive behavior in rats. Psychopharmacology (Berl) 134:392–400CrossRefGoogle Scholar
  16. de Almeida RMM, Miczek KA (2002) Aggression escalated by social instigation or by discontinuation of reinforcement (“frustration”) in mice: inhibition by anpirtoline-a 5-HT1B receptor agonist. Neuropsychopharmacology 27:171–181PubMedCrossRefGoogle Scholar
  17. de Almeida RMM, Nikulina EM, Faccidomo S, Fish EW, Miczek KA (2001) Zolmitriptan—a 5-HT1B/D agonist, alcohol, and aggression in mice. Psychopharmacology (Berl) 157:131–141CrossRefGoogle Scholar
  18. de Almeida RM, Ferrari PF, Parmigiani S, Miczek KA (2005) Escalated aggressive behavior, dopamine, serotonin and GABA. Eur J Pharmacol 526:51–64PubMedCrossRefGoogle Scholar
  19. de Almeida RM, Rosa MM, Santos DM, Saft DM, Benini Q, Miczek KA (2006) 5-HT1B receptors, ventral orbitofrontal cortex and aggressive behavior in mice. Psychopharmacology 185:441–450PubMedCrossRefGoogle Scholar
  20. de Boer SF, Koolhaas JM (2005) 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis. Eur J Pharmacol 526:125–139PubMedCrossRefGoogle Scholar
  21. de Boer SF, Lesourd M, Mocaer E, Koolhaas JM (1999) Selective antiaggressive effects of alnespirone in resident-intruder test are mediated via (5-hydroxytryptamine)1A receptors: a comparative pharmacological study with 8-hydroxy-2-dipropylaminotetralin, ipsapirone, buspirone, eltoprazine, and WAY-100635. J Pharmacol Exp Ther 288:1125–1133PubMedGoogle Scholar
  22. de Boer SF, Lesourd M, Mocaer E, Koolhaas JM (2000) Somatodendritic 5-HT(1A) autoreceptors mediate the anti-aggressive actions of 5-HT(1A) receptor agonists in rats: an ethopharmacological study with S-15535, alnespirone, and WAY-100635. Neuropsychopharmacology 23:20–33PubMedCrossRefGoogle Scholar
  23. de Boer SF, van der Vegt BJ, Koolhaas JM (2003) Individual variation in aggression of feral rodent strains: a standard for the genetics of aggression and violence? Behav Genet 33:485–501PubMedCrossRefGoogle Scholar
  24. De Groote L, Olivier B, Westenberg HG (2003) Role of 5-HT1B receptors in the regulation of extracellular serotonin and dopamine in the dorsal striatum of mice. Eur J Pharmacol 476:71–77PubMedCrossRefGoogle Scholar
  25. Fish EW, Faccidomo S, Miczek KA (1999) Aggression heightened by alcohol or social instigation in mice: reduction by the 5-HT1B receptor agonist CP-94,253. Psychopharmacology (Berl) 146:391–399CrossRefGoogle Scholar
  26. Fish EW, Sekinda M, Ferrari PF, Dirks A, Miczek KA (2000) Distress vocalizations in maternally separated mouse pups: modulation via 5-HT1A, 5-HT1B and GABAA receptors. Psychopharmacology 149:277–285PubMedCrossRefGoogle Scholar
  27. Fish EW, DeBold JF, Miczek KA (2002) Aggressive behavior as a reinforcer in mice: activation by allopregnanolone. Psychopharmacology (Berl) 163:459–466CrossRefGoogle Scholar
  28. Fish EW, DeBold JF, Miczek KA (2005) Escalated aggression as a reward: corticosterone and GABAA positive modulators in mice. Psychopharmacology 182:116–127PubMedCrossRefGoogle Scholar
  29. Fry W, Kelleher RT, Cook L (1960) A mathematical index of performance on fixed-interval schedules of reinforcement. J Exp Anal Behav 3:193–199PubMedCrossRefGoogle Scholar
  30. Fuller RW (1996) The influence of fluoxetine on aggressive behavior. Neuropsychopharmacology 14:77–81PubMedCrossRefGoogle Scholar
  31. Geyer MA (1996) Serotonergic functions in arousal and motor activity. Behav Brain Res 73:31–35PubMedCrossRefGoogle Scholar
  32. Haller J, Kruk MR (2006) Normal and abnormal aggression: human disorders and novel laboratory models. Neurosci Biobehav Rev 30:292–303PubMedCrossRefGoogle Scholar
  33. Heiligenstein JH, Beasley CM Jr, Potvin JH (1993) Fluoxetine not associated with increased aggression in controlled clinical trials. Int Clin Psychopharmacol 8:277–280PubMedCrossRefGoogle Scholar
  34. Knobelman DA, Kung HF, Lucki I (2000) Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors. J Pharmacol Exp Ther 292:1111–1117PubMedGoogle Scholar
  35. Koe BK, Lebel LA, Fox CB, Macor JE (1992a) Binding and uptake studies with [H3]CP-93,129, a radiolabeled selective 5-HT1B receptor ligand. Drug Dev Res 25:67–74CrossRefGoogle Scholar
  36. Koe BK, Nielsen JA, Macor JE, Heym J (1992b) Biochemical and behavioral studies of the 5-HT1B receptor agonist, CP-94, 253. Drug Dev Res 26:241–250CrossRefGoogle Scholar
  37. Macor JE, Burkhart CA, Heym JH, Ives JL, Lebel LA, Newman ME, Nielsen JA, Ryan K, Schulz DW, Torgersen LK, Koe BK (1990) 3-(1,2,5,6-Tetrahydropyrid-4-yl) pyrrolo [3,2-b] pyrid-5-one: a potent and selective serotonin (5HT1B) agonist and rotationally restricted phenolic analogue of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl) indole. J Med Chem 33:2087–2093PubMedCrossRefGoogle Scholar
  38. Martinez M, Guillen-Salazar F, Salvador A, Simon VM (1995) Successful intermale aggression and conditioned place preference in mice. Physiol Behav 58:323–328PubMedCrossRefGoogle Scholar
  39. Meisel RL, Joppa MA (1994) Conditioned place preference in female hamsters following aggressive or sexual encounters. Physiol Behav 56:1115–1118PubMedCrossRefGoogle Scholar
  40. Miczek KA, de Almeida RMM (2001) Oral drug self-administration in the home cage of mice: alcohol-heightened aggression and inhibition by the 5-HT1B agonist anpirtoline. Psychopharmacology (Berl) 157:421–429CrossRefGoogle Scholar
  41. Miczek KA, O’Donnell JM (1978) Intruder-evoked aggression in isolated and nonisolated mice: effects of psychomotor stimulants and l-dopa. Psychopharmacology (Berl) 57:47–55CrossRefGoogle Scholar
  42. Miczek KA, Maxson SC, Fish EW, Faccidomo S (2001) Aggressive behavioral phenotypes in mice. Behav Brain Res 125:167–181PubMedCrossRefGoogle Scholar
  43. Miczek KA, Fish EW, DeBold JF, de Almeida RMM (2002) Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and γ-aminobutyric acid systems. Psychopharmacology 163:434–458PubMedCrossRefGoogle Scholar
  44. Miczek KA, Faccidomo SP, Fish EW, DeBold JF (2006) Neurochemistry and molecular neurobiology of aggressive behavior. In: JD Blaustein (ed) Behavioral neurochemistry, neuroendocrinology and molecular neurobiology. Handbook of neurochemistry and molecular biology. Kluwer, New YorkGoogle Scholar
  45. Monroe RR (1975) Anticonvulsants in the treatment of aggression. J Nerv Ment Dis 160:119–126PubMedCrossRefGoogle Scholar
  46. Mos J, Olivier B, Poth M, Aken H (1992) The effects of intraventricular administration of eltoprazine, 1-(3-trifluoromethylphenyl) piperazine hydrochloride and 8-OH-DPAT on resident intruder aggression in the rat. Eur J Pharmacol 212:295–298PubMedCrossRefGoogle Scholar
  47. Mos J, Olivier B, Poth M, van Oorschot R, Van Aken H (1993) The effects of dorsal raphe administration of eltoprazine TF and Ipp and 8-OH-DPAT on resident intruder aggression in the rat. Eur J Pharmacol 238:411–415PubMedCrossRefGoogle Scholar
  48. Mos J, Vanaken HHM, van Oorschot R, Olivier B (1996) Chronic treatment with eltoprazine does not lead to tolerance in its antiaggressive action, in contrast to haloperidol. Eur Neuropsychopharmacol 6:1–7PubMedCrossRefGoogle Scholar
  49. Olivier B, Mos J (1986) Serenics and aggression. Stress Med 2:197–209CrossRefGoogle Scholar
  50. Olivier B, van Oorschot R (2005) 5-HT1B receptors and aggression: a review. Eur J Pharmacol 526:207–217PubMedCrossRefGoogle Scholar
  51. Olivier B, Mos J, Rasmussen D (1990) Behavioural pharmacology of the serenic, eltoprazine. Rev Drug Metab Drug Interact 8:31–83Google Scholar
  52. Olivier B, Mos J, Van Oorschot R, Hen R (1995) Serotonin receptors and animal models of aggressive behavior. Pharmacopsychiatry 28:80–90PubMedCrossRefGoogle Scholar
  53. Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates. Second edition. San Diego: Academic PressGoogle Scholar
  54. Puig MV, Artigas F, Celada P (2005) Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. Cereb Cortex 15:1–14PubMedCrossRefGoogle Scholar
  55. Ramboz S, Saudou F, Amara DA, Belzung C, Segu L, Misslin R, Buhot MC, Hen R (1996) 5-HT1B receptor knock out: behavioral consequences. Behav Brain Res 73:305–312PubMedCrossRefGoogle Scholar
  56. Ratey JJ, Gordon A (1993) The psychopharmacology of aggression: toward a new day. Psychopharmacol Bull 29:65–73PubMedGoogle Scholar
  57. Sari Y (2004) Serotonin1B receptors: from protein to physiological function and behavior. Neurosci Biobehav Rev 28:565–582PubMedCrossRefGoogle Scholar
  58. Sari Y, Miquel MC, Brisorgueil MJ, Ruiz G, Doucet E, Hamon M et al (1999) Cellular and subcellular localization of 5-hydroxytryptamine1b receptors in the rat central nervous system: immunocytochemical, autoradiographic and lesion studies. Neuroscience 88:899–915PubMedCrossRefGoogle Scholar
  59. Saudou F, Amara DA, Dierich A, Lemeur M, Ramboz S, Segu L et al (1994) Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265:1875–1878PubMedCrossRefGoogle Scholar
  60. Siegel A, Roeling TAP, Gregg TR, Kruk MR (1999) Neuropharmacology of brain-stimulation-evoked aggression. Neurosci Biobehav Rev 23:359–389PubMedCrossRefGoogle Scholar
  61. Sijbesma H, Schipper J, De Kloet ER, Mos J, Van Aken H, Olivier B (1991) Postsynaptic 5-HT1 receptors and offensive aggression in rats: a combined behavioural and autoradiographic study with eltoprazine. Pharmacol Biochem Behav 38:447–458PubMedCrossRefGoogle Scholar
  62. Silverman AP (1965) Ethological and statistical analysis of drug effects on the social behaviour of laboratory rats. Br J Pharmacol 24:579–590Google Scholar
  63. Tellegen A, Horn JM, Legrand RG (1969) Opportunity for aggression as a reinforcer in mice. Psychon Sci 14:104–105Google Scholar
  64. van der Vegt BJ, Lieuwes N, van de Wall EHEM, Kato K, Moya-Albiol L, Martinez-Sanchis S, de Boer SF, Koolhaas JM (2003a) Activation of serotonergic neurotransmission during the performance of aggressive behavior in rats. Behav Neurosci 117:667–674PubMedCrossRefGoogle Scholar
  65. van der Vegt BJ, Lieuwes N, Cremers TIFH, de Boer SF, Koolhaas JM (2003b) Cerebrospinal fluid monoamine and metabolite concentrations and aggression in rats. Horm Behav 44:199–208PubMedCrossRefGoogle Scholar
  66. Vitiello B, Stoff DM (1997) Subtypes of aggression and their relevance to child psychiatry. J Am Acad Child Adolesc Psych 36:307–315CrossRefGoogle Scholar
  67. Winslow JT, Miczek KA (1984) Habituation of aggressive behavior in mice: a parametric study. Aggress Behav 10:103–113CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Makoto Bannai
    • 1
    • 3
  • Eric W. Fish
    • 1
  • Sara Faccidomo
    • 1
  • Klaus A. Miczek
    • 1
    • 2
    Email author
  1. 1.Department of PsychologyTufts UniversityMedford and BostonUSA
  2. 2.Department of Psychiatry, Pharmacology, and NeuroscienceTufts UniversityMedfordUSA
  3. 3.Research Institute for Health FundamentalsAjinomoto Co., Inc.KawasakiJapan

Personalised recommendations